| 1440964-89-5 Basic information More.. |
Product Name: | PLB-1001 | Synonyms: | PLB-1001 ;BOZITINIB;BOZITINIB (PLB-1001);CBT-101;1,2,4-Triazolo[4,3-b]pyridazine, 6-(1-cyclopropyl-1H-pyrazol-4-yl)-3-[difluoro(6-fluoro-2-methyl-2H-indazol-5-yl)methyl]-;6-(1-cyclopropylpyrazol-4-yl)-3-[difluoro-(6-fluoro-2-methylindazol-5-yl)methyl]-[1,2,4]triazolo[4,3-b]pyridazine;Vebreltinib;6-(1-cyclopropyl-1H-pyrazol-4-yl)-3-(difluoro(6-fluoro-2-methyl-2H-indazol-5-yl)methyl)-[1,2,4]triazolo[4,3-b]pyridazine | CAS: | 1440964-89-5 | MF: | C20H15F3N8 | MW: | 424.38 | EINECS: | | Mol File: | 1440964-89-5.mol |  |
PLB-1001 manufacturers
- Bozitinib
-
- US $98.00-372.00 / mg
- 2025-07-30
- CAS:1440964-89-5
- Min. Order:
- Purity: 99.48%
- Supply Ability: 10g
- Bozitinib
-
- US $98.00-372.00 / mg
- 2025-07-30
- CAS:1440964-89-5
- Min. Order:
- Purity: 99.48%
- Supply Ability: 10g
|
1440964-89-5
Recommend Suppliers |
|